Product Images Famotidine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Famotidine NDC 70771-1846 by Zydus Lifesciences Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

40 mg/4 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 01

40 mg/4 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 01

40 mg/4 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 02

40 mg/4 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 02

This text provides information about Famotidine Injection, USP 40 mg/4 mL intended for intravenous use after dilution. Each mL contains famotidine USP 10 mg along with specified inactive ingredients. The medication is stored at 2° to 8°C (36° to 46°F). For detailed preparation instructions and adult dosage, refer to the package insert.*

200 mg/20 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 03

200 mg/20 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 03

Substrate: 350 gsm FBB carton with inner side poly coated, Aqua varnish. Special Instructions: The carton printing should be done with benzophenone free ink. Carton with inbuilt partition. Form of supply: Bundle. Famotidine Injection, USP, 200 mg/20 mL. Manufactured by Cadia Healthcare Ltd, Vadodara, India. Store at 2° to 8°C (36° to 46°F). For intravenous use only after dilution. Protect from light. Each box contains 10 x 20 mL Multiple-Dose Vials. Retain in carton until time of use.*

200 mg/20 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 04

200 mg/20 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 04

This is a description for Famotidine injection, USP, containing 200 mg/20 mL (10 mg/mL) for intravenous use. It should only be used after dilution and comes in a 20 mL multiple-dose vial. The preparation includes Famotidine USP 10 mg per mL along with L-aspartic acid, mannitol, and Water for Injection as inactive ingredients. Benzyl alcohol at 0.9% is added as a preservative. Storage between 2° to 8°C (36° to 46°F) is recommended. Finally, it is manufactured by Cadila Healthcare Limited in Vadodara, India.*

20 mg/2 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 05

20 mg/2 mL (10 mg/mL) carton label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 05

This text provides information about Famotidine Injection, USP 20 mg/2 mL solution for intravenous use after dilution. It includes details on its composition, storage instructions, preparation of intravenous solutions, and dosage guidance. The text also mentions the manufacturer, 3 Single-Dose Vials, restrictions on use, and the need for dilution before administration.*

20 mg/2 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 06

20 mg/2 mL (10 mg/mL) vial label - 6c2dd6fd 9bf9 4046 8166 86d8816be1cb 06

This text provides information about Famotidine Injection, USP for the preparation of intravenous solutions. The dosage and concentration are indicated, and it is specified that the solution is for intravenous use only after dilution. The product is in a 2 mL single-dose vial. Made in India.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.